Atara Biotherapeutics (ATRA) Other Non-Current Assets (2013 - 2026)

Atara Biotherapeutics' Other Non-Current Assets history runs 14 years deep, the most recent figure standing at $890000.0 for Q1 2026.

• Quarterly Other Non-Current Assets fell 68.71% year-over-year to $890000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $890000.0 (down 68.71% YoY) and the FY2025 annual result came in at $886000.0, down 71.45% from the prior year.
• Other Non-Current Assets was $890000.0 for Q1 2026 at Atara Biotherapeutics, roughly flat from $886000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $7.0 million in Q4 2022 and bottomed at $881000.0 in Q3 2025.
• A 5-year average of $3.4 million and a median of $3.2 million in 2024 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets surged 484.83% — and 2025, when it sank 74.31%.
• Atara Biotherapeutics' Other Non-Current Assets stood at $7.0 million in 2022, then slumped by 30.98% to $4.8 million in 2023, then plunged by 35.94% to $3.1 million in 2024, then tumbled by 71.45% to $886000.0 in 2025, then climbed by 0.45% to $890000.0 in 2026.
• Business Quant data shows ATRA's Other Non-Current Assets at $890000.0 in Q1 2026, $886000.0 in Q4 2025, and $881000.0 in Q3 2025.